N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure
Jacky T.P. Siu, Aaron M Tejani, Trina Nguyen, Ricky D. Turgeon
Abstract
Jacky T.P. Siu, Aaron M Tejani, Trina Nguyen, Ricky D. Turgeon
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the benefits and harms of N‐acetylcysteine compared with placebo in people with non‐paracetamol‐related acute liver failure.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the benefits and harms of N‐acetylcysteine compared with placebo in people with non‐paracetamol‐related acute liver failure.
Key concepts: Acetylcysteine, Acetaminophen, Liver failure, Medicine, Placebo, acetaminophen overdose, Intervention (counseling), Protocol (science)